OTCMKTS:ONCS
Delisted
OncoSec Medical Incorporated Stock News
$0.277
+0 (+0%)
At Close: Sep 22, 2023
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
OncoSec Receives $850,000 from The Australian Research and Development (R&D) Tax Incentive Program for TAVO™ R&D Work in 2019
12:30pm, Wednesday, 11'th Mar 2020
OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced that it has received a Research and Develo
OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced that the class action and related books an
Xencor (NASDAQ:XNCR) vs. OncoSec Medical (NASDAQ:ONCS) Critical Comparison
08:24am, Friday, 21'st Feb 2020
Xencor (NASDAQ:XNCR) and OncoSec Medical (NASDAQ:ONCS) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institu
OncoSec Strengthens its Board of Directors with Three New Appointments
01:30pm, Tuesday, 11'th Feb 2020
OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced changes to its Board of Directors (the "Bo
Clinical Cancer Research highlights OncoSec's Merkel Cell Carcinoma Clinical Study on the Cover of its February Issue
01:30pm, Tuesday, 04'th Feb 2020
OncoSec Medical Incorporated ("OncoSec") (Nasdaq: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced the publication of data showing that TAVO™ (plasmid-base
OncoSec Medical Incorporated ("OncoSec") (Nasdaq: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced data from a feasibility study of its visceral lesion appli
Analyzing OncoSec Medical (NASDAQ:ONCS) and CymaBay Therapeutics (NASDAQ:CBAY)
06:32am, Tuesday, 14'th Jan 2020
OncoSec Medical (NASDAQ:ONCS) and CymaBay Therapeutics (NASDAQ:CBAY) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength o
